Published in J Dermatol Surg Oncol on November 01, 1985
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene (2007) 1.77
Bilateral synchronous testis tumors of different histology in a patient with the acquired immunodeficiency syndrome related complex. J Urol (1990) 1.40
Pagetoid spread of intratubular germ cell neoplasia into rete testis: a morphologic and histochemical study of 100 orchiectomy specimens with invasive germ cell tumors. Hum Pathol (1994) 1.39
Imaging features of focal breast fibrosis: mammographic-pathologic correlation of noncalcified breast lesions. AJR Am J Roentgenol (1999) 1.38
P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol (1990) 1.27
Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol (1999) 1.24
Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg (1988) 1.19
Perinucleolar compartment prevalence has an independent prognostic value for breast cancer. Cancer Res (2005) 1.14
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene (2010) 1.11
Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol (1999) 1.02
Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. Cancer Res (1986) 1.02
Cell type specific expression of steroid 5 alpha-reductase 2. J Urol (1994) 1.02
Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma? Ann Surg (1985) 1.02
Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol (1982) 0.94
Flow cytometric analysis of paraffin-embedded tumors: implications for diagnostic pathology. Hum Pathol (1986) 0.94
Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res (1997) 0.94
Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp Hematol (1995) 0.93
Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology (2005) 0.90
Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease. J Urol (1994) 0.90
Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor. Cancer Res (1983) 0.90
Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum Pathol (1986) 0.89
Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon. Lab Invest (1981) 0.89
Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch Biochem Biophys (1995) 0.88
Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines. Int J Cancer (1993) 0.87
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother (1993) 0.85
Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx. Auris Nasus Larynx (2002) 0.85
Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors. Mod Pathol (1989) 0.85
Retrospective DNA analysis of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (1986) 0.84
A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer (2010) 0.84
Primary adenocarcinomas of the human urinary bladder: histochemical, immunological and ultrastructural studies. Virchows Arch A Pathol Anat Histol (1981) 0.84
Pathology of superficial bladder cancer with emphasis on carcinoma in situ. Urology (1985) 0.84
Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx. Laryngoscope (1999) 0.84
Variability in the expression of the O(H) antigen in human transitional epithelium. J Urol (1981) 0.84
Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast. Breast J (2001) 0.84
Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues. Clin Cancer Res (1997) 0.83
Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder. J Urol (1982) 0.83
Primary leiomyosarcoma of the seminal vesicle. Urology (1994) 0.83
Distribution of blood group substances in normal human colon. Use of the unlabeled antibody (PAP) immunoperoxidase technic to identify A and B blood group substances. Am J Clin Pathol (1981) 0.83
ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. Mol Endocrinol (2014) 0.82
Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method. Am J Clin Pathol (1981) 0.82
Hemolytic-uremic syndrome associated with mitomycin therapy. Cancer Treat Rep (1982) 0.82
Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation. J Nucl Med (1990) 0.82
Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck (2001) 0.81
Precision of DNA flow cytometry in inter-institutional analyses. Cytometry (1991) 0.81
Cutaneous phaeohyphomycosis caused by a rare fungal pathogen, Hormonema dematioides: successful treatment with ketoconazole. J Am Acad Dermatol (1990) 0.81
Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int J Cancer (1996) 0.81
ABO blood type predicts the cytolocalization of anti-P-glycoprotein monoclonal antibody reactivity in human colon and ureter. Hum Pathol (1990) 0.81
Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol (1997) 0.80
Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope (1998) 0.80
Superior vena cava syndrome secondary to Candida thrombophlebitis complicating parenteral alimentation. J Pediatr (1977) 0.80
Nucleolar organizer regions in squamous cell carcinoma of the head and neck. Laryngoscope (1992) 0.80
Origin of multiple "primary" colon carcinomas. A retrospective flow cytometric study. Cancer (1986) 0.80
The tubular variant of adenoid cystic carcinoma of the Bartholin's gland. Am J Clin Pathol (1994) 0.80
Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents. Int J Cancer (1995) 0.79
Flow cytometric analysis of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis. Cancer (1986) 0.79
Ligand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival. Horm Cancer (2013) 0.78
Ethanol fixation of bladder irrigation specimens for flow cytometric analysis. A multiinstitutional study from the bladder cancer flow cytometry network. Cancer (1989) 0.78
Multiparameter flow cytometric analysis of colon polyps. Am J Clin Pathol (1987) 0.78
Monoclonal antibody to Pneumocystis carinii. Comparison with silver stain in bronchial lavage specimens. Am J Clin Pathol (1992) 0.78
Mutation of p53 in squamous cell cancer of the head and neck: relationship to tumor cell proliferation. Laryngoscope (1997) 0.77
Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer. Arch Otolaryngol Head Neck Surg (1998) 0.77
Measurement variability in DNA flow cytometry of replicate samples. Cytometry (1989) 0.77
Temperature alters lipopolysaccharide-induced cytokine secretion by RAW 264.7 cells. Scand J Immunol (2003) 0.77
Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncol Res (1998) 0.77
Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer. Head Neck (1997) 0.76
Flow cytometric analysis of heterogeneity in blood group-related antigen expression in a human urinary bladder carcinoma cell line, 647V. Cancer Res (1985) 0.76
Correlation between ABO blood type and Golgi P-glycoprotein expression in epithelia. Lancet (1990) 0.76
Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function. Int J Cancer (1996) 0.76
Tuberculous bronchiolitis. N Engl J Med (1996) 0.75
Laboratory assessment of P-glycoprotein in cancer chemosensitivity testing. Hum Pathol (1990) 0.75
Adrenal carcinoma presenting as a lesion resembling cutaneous angiosarcoma. Cancer (1991) 0.75
Bone densitometry of osteopetrosis in an adolescent girl. Clin Nucl Med (1990) 0.75
Modulation of the metastatic phenotype by 13-cis-retinoic acid. J Natl Cancer Inst (1987) 0.75
Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma. Prog Clin Biol Res (1984) 0.75
Histologic diagnosis of benign adnexal skin tumors. An algorithmic approach. J Am Acad Dermatol (1985) 0.75
Variable expression of P-glycoprotein in normal, inflamed, and dysplastic areas in ulcerative colitis. Dis Colon Rectum (1992) 0.75
In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region. Cell Prolif (1995) 0.75
Induction of reversible changes in cell-surface glycoconjugates and lung colonization potential by 13-cis retinoic acid. J Cell Biochem (1988) 0.75
The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland. Am J Clin Pathol (1988) 0.75
Natural killer cell cytotoxicity and the multidrug resistance gene. Transplant Proc (1993) 0.75
Surface charge distribution in normal and transformed rat bladder epithelial cells in vitro. Lab Invest (1985) 0.75
A source of toxic gas leakage in a nuclear medicine department. J Nucl Med (1991) 0.75
Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder. Cancer (1985) 0.75
Malignant cell detection and cervical cancer screening. Anal Quant Cytol (1984) 0.75
Blood group antigens in tumor cell membranes. Biomembranes (1983) 0.75
Inverted papilloma of the urinary bladder: ultrastructural and immunologic studies. Cancer (1980) 0.75
Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapy. Bone Marrow Transplant (1999) 0.75
Flow cytometry in melanoma. Cancer Treat Res (1988) 0.75
Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion. Int J Dermatol (1993) 0.75
Technology assessment of urinary flow cytometry. Hum Pathol (1987) 0.75
Blood group antigens and ploidy as prognostic factors in urinary bladder carcinoma. Monogr Pathol (1986) 0.75
PCR production of a digoxigenin-labeled probe for the detection of human cytomegalovirus in tissue sections. Diagn Mol Pathol (1994) 0.75
Arias-Stella reaction with prominent nuclear pseudoinclusions simulating herpetic endometritis. Diagn Gynecol Obstet (1982) 0.75
Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy. Clin Cancer Res (1996) 0.75
Comparison of automated and manual techniques for analysis of DNA frequency distributions in bladder washings. Cytometry (1988) 0.75